类风湿关节炎的药物治疗近况(4)
[14] Mok CC.Rituximab for the treatment of rheumatoid arthritis：anupdate[J].Drug Des Devel Ther，2013，27(8) ：87-100.
[15] Schmidt W A，Schicke B，Krause A，et al.How effective is rituximab inrheumatoid arthritis：Lessons learned from clinical practice[J].Z Rheumatol，2009.
[16] Emery P，Fleischmann R，Filipowicz Sosnowska A，et al.The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment.Results of a phase IIb randomized，double-blind，placebo-controlled，dose-ranging trial[J].Arthritis Rheum，2006，54(5)：1390-1400.
[17] Romano C，Del Mastro A，Sellitto A，et al.Tocilizumab reduces complement C3 and C4 serum levels in rheumatoid arthritis patients[J].Clin Rheumatol，2018，37(6) ：1695-1700.
[18] Fernández-Díaz C，Loricera J，Casta eda S，et al.Abatacept inpatients with rheu-m atoid arthritis and interstitial lung disease： Anational multicenter study of 63 patients[J].Semin Arthritis Rheum，2018，48(1) ：22-27.
[19] Calabrese LH，Rose John S.IL-6 biology： implications for clinical targeting in rheumatic disease[J].Nat Rev Rheumatol，2014，10(12) ：720-727.
[2020-09-07收稿], http://www.100md.com(薛利敏 罗昆 王君雅 曲艺 王沛然)
[15] Schmidt W A，Schicke B，Krause A，et al.How effective is rituximab inrheumatoid arthritis：Lessons learned from clinical practice[J].Z Rheumatol，2009.
[16] Emery P，Fleischmann R，Filipowicz Sosnowska A，et al.The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment.Results of a phase IIb randomized，double-blind，placebo-controlled，dose-ranging trial[J].Arthritis Rheum，2006，54(5)：1390-1400.
[17] Romano C，Del Mastro A，Sellitto A，et al.Tocilizumab reduces complement C3 and C4 serum levels in rheumatoid arthritis patients[J].Clin Rheumatol，2018，37(6) ：1695-1700.
[18] Fernández-Díaz C，Loricera J，Casta eda S，et al.Abatacept inpatients with rheu-m atoid arthritis and interstitial lung disease： Anational multicenter study of 63 patients[J].Semin Arthritis Rheum，2018，48(1) ：22-27.
[19] Calabrese LH，Rose John S.IL-6 biology： implications for clinical targeting in rheumatic disease[J].Nat Rev Rheumatol，2014，10(12) ：720-727.
[2020-09-07收稿], http://www.100md.com(薛利敏 罗昆 王君雅 曲艺 王沛然)